Program Schedule

1209
Dose Adjustment of Anti-Infective Agents in Obese Patients

Session: Symposium: When Bigger is Not Better - Infectious Diseases and Obesity
Friday, October 10, 2014: 3:00 PM
Room: The Pennsylvania Convention Center: 115-ABC
Manjunath Pai, PharmD, BCPS, Albany College of Pharmacy and Health Sciences, Albany, NY

CURRICULUM VITAE
May 2009
MANJUNATH (AMIT) P. PAI
Education
Doctor of Pharmacy (1994 - 1998), College of Pharmacy, The University of Texas at Austin & The University of Texas, Health Sciences Center at San Antonio
Post Doctoral Training
Pharmacy Practice Residency (1998 - 1999), Clinical Pharmacology Service, Bassett Healthcare, Cooperstown, New York
Fellowship in Infectious Diseases Pharmacotherapy (1999 - 2001), College of Pharmacy, University Of Illinois at Chicago
Clinical Research Scholars Program (2001 - 2003), General Clinical Research Center, University of New Mexico
Clinical and Translation Science Center Scholar (2006 - 2008), CTSC, School of Medicine, University of New Mexico
Certification
Board Certified Pharmacotherapy Specialist (2003-2010), Board of Pharmaceutical Specialties
Employment History
Associate Professor , Tenure Track (April 2009 - Present), Albany College of Pharmacy and Health Sciences, Albany, New York
Scientist, Translational Medicine (October 2008 - March 2009), Institute for Clinical Pharmacodynamics, Ordway Research Institute, Latham, New York
Associate Professor of Pharmacy- Tenured (July 2007 - September 2008), Assistant Professor of Pharmacy (August 2001 - June 2007), Pharmacy Practice, Pharmacy Administration Graduate Program, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico
Honors and Awards
Teacher of the Year, College of Pharmacy, UNM, Albuquerque, NM. (2008)
Young Investigator Award, Society of Infectious Diseases Pharmacists (2007)
Drug Therapy Research Award, American Society of Health Systems Pharmacy (2007)
Fellowship Research Award, College of Pharmacy, UIC, Chicago, IL. (2001)
Selected Grants and Awards
1.
Clinical and Translational Science Center, Research Career Development Award. 0.75 FTE (~$75,000/year). Brain antifungal pharmacodynamics: Use of 19F-Magnetic Resonance Spectroscopy and Microdialysis. University of New Mexico, College of Pharmacy. Project Period 2006-2008. Principal Investigator.
2.
General Clinical Research Center Grant, NCRR, NIH 5 M01 RR00997. $3,080. Accuracy of creatinine clearance equations in morbidly obese patients: Influence of central body fat distribution. University of New Mexico, College of Pharmacy. Project Period 2005-2007. Principal Investigator.
3.
Society of Infectious Diseases Pharmacists. $20,000. Pharmacodynamic evaluation of antifungals in an in vitro model of Candida spp. infective endocarditis. University of New Mexico, College of Pharmacy. Project Period 2005-2006. Principal Investigator.
4.
Cubist Pharmaceuticals, Inc. Independent Research Grant. $26,069. Investigator Initiated. Characterization of daptomycin pharmacokinetics and glomerular filtration rate in morbidly obese patients. University of New Mexico, College of Pharmacy. Project Period: 2004-2005. Principal Investigator.
5.
American Association of Colleges of Pharmacy, New Investigator Award. $10,000. The effect of calcium supplementation on the steady-state pharmacokinetics of oral once daily 750-milligram doses of levofloxacin in adult cystic fibrosis patient. University of New Mexico, College of Pharmacy. Project Period 2003-2004. Principal Investigator.
6.
General Clinical Research Center Grant, NCRR, NIH 5 M01 RR00997. $11,292. Assessment of effective renal plasma flow, enzymuria and cytokine release during the administration of amphotericin B in healthy volunteers. University of New Mexico, College of Pharmacy. Project Period 2003



<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek